SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Exact Sciences Corp. – ‘8-K’ for 1/11/21

On:  Friday, 1/15/21, at 8:59am ET   ·   For:  1/11/21   ·   Accession #:  1104659-21-4471   ·   File #:  1-35092

Previous ‘8-K’:  ‘8-K’ on 1/11/21 for 1/10/21   ·   Next:  ‘8-K’ on / for 2/16/21   ·   Latest:  ‘8-K’ on / for 2/21/24   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/15/21  Exact Sciences Corp.              8-K:5       1/11/21   10:182K                                   Toppan Merrill/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     26K 
 6: R1          Cover                                               HTML     46K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 5: XML         XBRL Instance -- tm213269d1_8k_htm                   XML     14K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- exas-20210111_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- exas-20210111_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- exas-20210111                         XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
10: ZIP         XBRL Zipped Folder -- 0001104659-21-004471-xbrl      Zip     11K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0001124140  i false 0001124140 2021-01-11 2021-01-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):   i January 11, 2021

 

 i EXACT SCIENCES CORPORATION

(Exact Name of Registrant as Specified in Charter)

 

 i Delaware    i 001-35092    i 02-0478229
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

 i 5505 Endeavor Lane

 i Madison,  i WI  i 53719

(Address of Principal Executive Offices)(Zip Code)

 

Registrant’s telephone number, including area code:  ( i 608)  i 284-5700

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 i ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
 i Common Stock, $0.01 par value per share  i EXAS  i The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  i ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 C: 

 

 

 

Item 5.02Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

 

Andrew Slavitt has been appointed by President-elect Joseph R. Biden, Jr. as White House Senior Advisor for COVID Response. As required by that appointment, on January 11, 2021, Mr. Slavitt submitted his resignation as a member of the Board of Directors of Exact Sciences Corporation.

 

 C: 

 C: 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  EXACT SCIENCES CORPORATION
 
Date: January 15, 2021 By: /s/ Jeffrey T. Elliott   
    Jeffrey T. Elliott
    Chief Financial Officer

 

 C: 

 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:1/15/21
For Period end:1/11/213,  8-K
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/10/22  Exact Sciences Corp.              424B7                  1:624K
 6/07/21  Exact Sciences Corp.              424B7                  1:610K
Top
Filing Submission 0001104659-21-004471   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 5:51:07.2am ET